Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 33 | 2025 | 184 | 5.530 |
Why?
|
| Bronchopulmonary Dysplasia | 19 | 2025 | 31 | 5.190 |
Why?
|
| Infant, Premature, Diseases | 9 | 2021 | 47 | 2.860 |
Why?
|
| Oxygen Inhalation Therapy | 7 | 2025 | 57 | 2.470 |
Why?
|
| Infant, Newborn | 44 | 2025 | 1355 | 2.470 |
Why?
|
| Apnea | 5 | 2017 | 32 | 1.750 |
Why?
|
| Oximetry | 7 | 2025 | 48 | 1.750 |
Why?
|
| Infant | 27 | 2024 | 1649 | 1.390 |
Why?
|
| Gestational Age | 10 | 2025 | 189 | 1.250 |
Why?
|
| Oxygen | 6 | 2022 | 315 | 1.190 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2017 | 57 | 1.020 |
Why?
|
| Child Restraint Systems | 3 | 2017 | 5 | 0.960 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 2 | 2024 | 4 | 0.930 |
Why?
|
| Length of Stay | 3 | 2017 | 811 | 0.900 |
Why?
|
| Carbon Dioxide | 2 | 2024 | 86 | 0.890 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2022 | 14 | 0.770 |
Why?
|
| Bradycardia | 4 | 2017 | 33 | 0.750 |
Why?
|
| Ventilator Weaning | 2 | 2011 | 20 | 0.740 |
Why?
|
| Home Care Services, Hospital-Based | 2 | 2020 | 5 | 0.730 |
Why?
|
| Intensive Care Units, Neonatal | 7 | 2025 | 81 | 0.700 |
Why?
|
| Caffeine | 3 | 2017 | 49 | 0.680 |
Why?
|
| Feeding Methods | 1 | 2019 | 9 | 0.630 |
Why?
|
| Ambulatory Care | 2 | 2024 | 311 | 0.630 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 54 | 0.610 |
Why?
|
| Monitoring, Physiologic | 3 | 2024 | 158 | 0.600 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 87 | 0.590 |
Why?
|
| Birth Weight | 2 | 2022 | 85 | 0.580 |
Why?
|
| Premature Birth | 4 | 2023 | 112 | 0.580 |
Why?
|
| Neuromuscular Diseases | 2 | 2017 | 22 | 0.570 |
Why?
|
| Humans | 49 | 2025 | 63281 | 0.560 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 28 | 0.550 |
Why?
|
| Central Nervous System Stimulants | 2 | 2017 | 65 | 0.550 |
Why?
|
| Term Birth | 1 | 2016 | 7 | 0.530 |
Why?
|
| Down Syndrome | 1 | 2017 | 47 | 0.520 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 57 | 0.510 |
Why?
|
| Patient Discharge | 7 | 2022 | 511 | 0.510 |
Why?
|
| Retrospective Studies | 15 | 2023 | 6624 | 0.500 |
Why?
|
| Home Care Services | 3 | 2025 | 98 | 0.500 |
Why?
|
| Hypoxia | 2 | 2014 | 115 | 0.490 |
Why?
|
| Asthma | 2 | 2017 | 440 | 0.490 |
Why?
|
| Child, Preschool | 13 | 2024 | 1988 | 0.470 |
Why?
|
| Respiration | 2 | 2024 | 89 | 0.460 |
Why?
|
| Health Care Costs | 1 | 2017 | 210 | 0.460 |
Why?
|
| Quality of Life | 2 | 2020 | 1223 | 0.450 |
Why?
|
| Body Weight | 2 | 2020 | 377 | 0.440 |
Why?
|
| Respiratory Aspiration | 1 | 2013 | 5 | 0.430 |
Why?
|
| Respiratory Mechanics | 2 | 2017 | 56 | 0.430 |
Why?
|
| Deglutition | 1 | 2013 | 19 | 0.430 |
Why?
|
| Female | 27 | 2025 | 32777 | 0.410 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 735 | 0.410 |
Why?
|
| Child | 14 | 2024 | 4522 | 0.400 |
Why?
|
| Equipment Failure | 1 | 2013 | 67 | 0.400 |
Why?
|
| Male | 24 | 2025 | 29804 | 0.400 |
Why?
|
| Eating | 1 | 2013 | 138 | 0.400 |
Why?
|
| Posture | 1 | 2013 | 127 | 0.390 |
Why?
|
| Patient Readmission | 2 | 2017 | 430 | 0.380 |
Why?
|
| Professional Practice | 1 | 2011 | 24 | 0.370 |
Why?
|
| Social Determinants of Health | 2 | 2025 | 130 | 0.350 |
Why?
|
| Hospitalization | 2 | 2023 | 1357 | 0.340 |
Why?
|
| Diuretics | 2 | 2025 | 62 | 0.340 |
Why?
|
| Patient Safety | 1 | 2013 | 243 | 0.330 |
Why?
|
| Infant Equipment | 1 | 2010 | 2 | 0.330 |
Why?
|
| Parents | 3 | 2024 | 390 | 0.320 |
Why?
|
| Receptors, IgG | 1 | 2007 | 41 | 0.280 |
Why?
|
| Trachea | 3 | 2017 | 84 | 0.270 |
Why?
|
| Risk Factors | 7 | 2021 | 5338 | 0.270 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2007 | 108 | 0.260 |
Why?
|
| Pneumonia, Bacterial | 1 | 2007 | 89 | 0.260 |
Why?
|
| Logistic Models | 4 | 2015 | 1275 | 0.260 |
Why?
|
| Boston | 3 | 2021 | 252 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 734 | 0.240 |
Why?
|
| Furosemide | 1 | 2025 | 21 | 0.240 |
Why?
|
| Infant, Extremely Low Birth Weight | 2 | 2016 | 6 | 0.230 |
Why?
|
| Air Pollution, Indoor | 1 | 2024 | 35 | 0.220 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1098 | 0.210 |
Why?
|
| Time Factors | 3 | 2025 | 3759 | 0.210 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 1543 | 0.210 |
Why?
|
| Pediatrics | 3 | 2017 | 254 | 0.210 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 935 | 0.200 |
Why?
|
| Cannula | 1 | 2022 | 26 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2021 | 3285 | 0.190 |
Why?
|
| United States | 8 | 2022 | 7829 | 0.190 |
Why?
|
| Polysomnography | 2 | 2021 | 57 | 0.190 |
Why?
|
| Reference Values | 2 | 2013 | 335 | 0.180 |
Why?
|
| Respiratory Tract Diseases | 1 | 2021 | 37 | 0.180 |
Why?
|
| Nutrition Policy | 1 | 2021 | 39 | 0.180 |
Why?
|
| Adolescent Development | 1 | 2021 | 16 | 0.180 |
Why?
|
| Lung | 2 | 2021 | 953 | 0.170 |
Why?
|
| Tracheomalacia | 2 | 2017 | 5 | 0.170 |
Why?
|
| Respiratory System Agents | 1 | 2020 | 6 | 0.170 |
Why?
|
| Child Development | 1 | 2021 | 85 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 136 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2024 | 683 | 0.160 |
Why?
|
| Body Mass Index | 2 | 2021 | 863 | 0.160 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2019 | 28 | 0.150 |
Why?
|
| Infant, Extremely Premature | 1 | 2019 | 37 | 0.150 |
Why?
|
| Respiration Disorders | 1 | 2019 | 25 | 0.150 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 53 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2020 | 209 | 0.150 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 297 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2016 | 2566 | 0.140 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 2571 | 0.140 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 2674 | 0.140 |
Why?
|
| Milk, Human | 1 | 2019 | 90 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 2 | 2010 | 96 | 0.140 |
Why?
|
| Mothers | 1 | 2021 | 275 | 0.140 |
Why?
|
| Outpatients | 3 | 2023 | 142 | 0.140 |
Why?
|
| Esophagoplasty | 1 | 2016 | 4 | 0.130 |
Why?
|
| Infant Care | 1 | 2016 | 20 | 0.130 |
Why?
|
| Esophageal Atresia | 1 | 2016 | 9 | 0.130 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2016 | 4 | 0.130 |
Why?
|
| Cost Savings | 1 | 2017 | 54 | 0.130 |
Why?
|
| New England | 2 | 2017 | 273 | 0.130 |
Why?
|
| Thoracotomy | 1 | 2016 | 46 | 0.130 |
Why?
|
| Anastomotic Leak | 1 | 2016 | 36 | 0.130 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 114 | 0.120 |
Why?
|
| Infant, Low Birth Weight | 2 | 2015 | 60 | 0.120 |
Why?
|
| Saliva | 1 | 2016 | 103 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2016 | 126 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 536 | 0.120 |
Why?
|
| Tracheobronchomalacia | 1 | 2015 | 1 | 0.120 |
Why?
|
| Bronchi | 1 | 2015 | 78 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2019 | 442 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 713 | 0.110 |
Why?
|
| Age Factors | 3 | 2021 | 1560 | 0.110 |
Why?
|
| Sucking Behavior | 1 | 2013 | 1 | 0.110 |
Why?
|
| Barium | 1 | 2013 | 7 | 0.110 |
Why?
|
| Health Status | 1 | 2016 | 435 | 0.110 |
Why?
|
| Inpatients | 1 | 2016 | 303 | 0.110 |
Why?
|
| Equipment Safety | 1 | 2013 | 22 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2016 | 866 | 0.100 |
Why?
|
| New York | 1 | 2013 | 144 | 0.100 |
Why?
|
| Prevalence | 1 | 2016 | 1377 | 0.100 |
Why?
|
| Respiratory Function Tests | 2 | 2024 | 189 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2016 | 1303 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 180 | 0.090 |
Why?
|
| Morbidity | 2 | 2022 | 113 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2013 | 198 | 0.090 |
Why?
|
| Tachykinins | 1 | 2011 | 7 | 0.090 |
Why?
|
| Equipment Design | 1 | 2013 | 349 | 0.090 |
Why?
|
| Complement C3a | 1 | 2011 | 7 | 0.090 |
Why?
|
| Vital Signs | 1 | 2011 | 12 | 0.090 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2011 | 25 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2013 | 768 | 0.090 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2011 | 35 | 0.090 |
Why?
|
| Pulmonary Medicine | 1 | 2011 | 41 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 1 | 2011 | 105 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2011 | 94 | 0.090 |
Why?
|
| Tracheotomy | 1 | 2010 | 7 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2013 | 305 | 0.080 |
Why?
|
| Contraindications | 1 | 2010 | 52 | 0.080 |
Why?
|
| Tracheostomy | 2 | 2023 | 36 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1084 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2017 | 5649 | 0.080 |
Why?
|
| Referral and Consultation | 2 | 2024 | 422 | 0.080 |
Why?
|
| Incidence | 1 | 2013 | 1375 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2010 | 182 | 0.070 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2007 | 1 | 0.070 |
Why?
|
| Complement C5a | 1 | 2007 | 5 | 0.070 |
Why?
|
| Capillary Permeability | 1 | 2007 | 16 | 0.070 |
Why?
|
| Cytokines | 2 | 2011 | 934 | 0.070 |
Why?
|
| Phagocytes | 1 | 2007 | 52 | 0.070 |
Why?
|
| Pseudomonas Infections | 1 | 2007 | 54 | 0.070 |
Why?
|
| Leukocytes | 1 | 2007 | 104 | 0.070 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 181 | 0.060 |
Why?
|
| Massachusetts | 2 | 2024 | 2075 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2007 | 264 | 0.060 |
Why?
|
| Babesiosis | 1 | 2006 | 12 | 0.060 |
Why?
|
| Transfusion Reaction | 1 | 2006 | 46 | 0.060 |
Why?
|
| Cell Movement | 1 | 2007 | 452 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2010 | 874 | 0.060 |
Why?
|
| Adult | 3 | 2024 | 16774 | 0.060 |
Why?
|
| Survival Rate | 1 | 2007 | 850 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1254 | 0.060 |
Why?
|
| Partial Pressure | 1 | 2024 | 9 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2024 | 57 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 108 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2021 | 753 | 0.050 |
Why?
|
| Communication Barriers | 1 | 2024 | 67 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 6238 | 0.050 |
Why?
|
| Child Health Services | 1 | 2024 | 63 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2025 | 738 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 860 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2023 | 30 | 0.050 |
Why?
|
| Child Day Care Centers | 1 | 2022 | 9 | 0.050 |
Why?
|
| Steroids | 1 | 2022 | 55 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2024 | 509 | 0.050 |
Why?
|
| Aftercare | 1 | 2021 | 76 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2022 | 100 | 0.050 |
Why?
|
| Echocardiography | 1 | 2024 | 501 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2021 | 115 | 0.040 |
Why?
|
| Inflammation | 1 | 2007 | 1146 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 202 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 228 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 3391 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 563 | 0.040 |
Why?
|
| Societies | 1 | 2019 | 24 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1649 | 0.040 |
Why?
|
| Mice | 2 | 2011 | 10827 | 0.040 |
Why?
|
| Registries | 1 | 2021 | 886 | 0.030 |
Why?
|
| Esophageal Stenosis | 1 | 2016 | 4 | 0.030 |
Why?
|
| Diverticulum | 1 | 2016 | 12 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 88 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1001 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 138 | 0.030 |
Why?
|
| Animals | 3 | 2011 | 20631 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 289 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 690 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 642 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2071 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 337 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2330 | 0.030 |
Why?
|
| Pneumonia | 1 | 2015 | 290 | 0.020 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2011 | 18 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2460 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 147 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1177 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4683 | 0.020 |
Why?
|
| Respiratory System Abnormalities | 1 | 2010 | 3 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 451 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 542 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 68 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 259 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 661 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 95 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 377 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 102 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2010 | 248 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 839 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 771 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 17541 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 2007 | 113 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 2107 | 0.020 |
Why?
|
| Babesia | 1 | 2006 | 1 | 0.020 |
Why?
|
| Prognosis | 1 | 2010 | 1750 | 0.010 |
Why?
|